The $749999 contract will see Tiba Biotech build on previous work to develop new a RNA-based vaccine against the H1N1 strain of the bird flu.
Read More at Source.
Read More at Source.
Read More at Source.
Read More at Source.
Read More at Source.
Read More at Source.
Read More at Source.
Read More at Source.
Read More at Source.
Read More at Source.
Read More at Source.